Drug discovery biotech firm Chemotargets and the Centre for Genomic Regulation (CRG) have signed a strategic agreement to accelerate the development of new targeted therapies that respond to unmet clinical…
Read More
The Innovative SME Seal, valid for three years, recognizes the high level of innovation in the projects, products and services of Chemotargets. Barcelona, June 1st, 2021. Chemotargets has been awarded…
In less than 12 months, the collaboration between Chemotargets and Galyan Bio yields a scaffold for first-in-class clinical candidates in difficult area of neurodegenerative disease. Chemotargets employed its proprietary AI-driven…
The Seal of Excellence certifies the high-quality of the CLARITY proposal aimed at enhancing its data coverage, artificial intelligence approaches and analytics tools for drug discovery. Barcelona, July 11th, 2019….
